Logo

Sanofi-Aventis Renews License for Genomatix Microarray Software

Sep 28, 2007
NEW YORK (GenomeWeb News) - Genomatix said yesterday that Sanofi-Aventis has renewed its multi-site license for its Microarray Analysis Pipeline software.
 
The software analyzes data for a number of micorarray applications, including gene expression, tiling microarrays, and ChIP-on-chip studies.
 
Sanofi-Aventis originally licensed the company’s GenomatixSuite software in 2005.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.